Consumers opting for more in-person, budget-friendly purchases
The Vision Council's third quarter Consumer inSights report shows that consumers are opting for budget-friendly eye wear options and making more in-person purchases. Online eye wear purchases have decreased, with…
With new Wegovy data in hand, Novo Nordisk will file for approval in MASH
Novo Nordisk's weight loss drug Wegovy showed promising results in a Phase 3 trial for people with nonalcoholic steatohepatitis (NASH), a fatty liver disease. 37% of patients on Wegovy experienced…
Preventing obesity in very young children could be in the palm of parents’ hands
A study led by Johns Hopkins Children's Center shows that using text messaging and electronic feedback alongside traditional in-clinic counseling for parents about feeding, playtime, and exercise can prevent young…
Bone chemistry reveals age and handedness of Tudor sailors
A recent study used Raman spectroscopy to analyze the clavicle bone chemistry of sailors who died on the Tudor warship Mary Rose. The findings revealed that protein was well preserved…
GLP-1s Show No Link to AKI With Anticancer Therapy
Patients undergoing cancer treatment are at a heightened risk for acute kidney injury (AKI), but a large retrospective analysis found no increased risk related to exposure to glucagon-like peptide-1 (GLP-1)…
Protein-Design Startup Archon Adds $20M to Show How ‘Cages’ Can Change Antibody Drugs
Antibodies, traditionally used as drugs due to scientists' manipulation, have limitations in their therapeutic window. Archon Biosciences, a Seattle-based startup, has developed a technology that changes the size and shape…
Zimmer Biomet reports increased net sales in third-quarter 2024 financial results
Zimmer Biomet announced its third-quarter 2024 financial results, reporting $1.824 billion in net sales and $249.1 million in net earnings. Despite challenges with their ERP implementation, the company highlighted their…
Pharmalittle: We’re reading about pharma risks in China, mitigating shortages, and more
As the workweek comes to an end, U.S. drugmakers and biotechs are reconsidering their reliance on Chinese partners for manufacturing, research, and ingredients due to rising geopolitical tensions. Companies like…
Mpox cases in Congo may be stabilizing. Experts say more vaccines are needed to stamp out virus
2-year-old Emile Miango, diagnosed with mpox, is receiving treatment in the epicenter of the outbreak in Congo. Although mpox cases in Congo are stabilizing, health experts are concerned about the…
Enhanced screening protocols for Candida auris improve hospital infection control
Researchers at Mount Sinai have developed enhanced hospital screening protocols for Candida auris, a drug-resistant fungal pathogen. The new guidelines aim to detect the harmful fungus in high-risk patients early…